Search
for
Sort by
Research 451–480 of 1000+
- Geriatric Dermatologic Therapy
- British Society for Dermatopathology: Summaries of Papers
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Endocrine-skin interactions
- Allergic contact dermatitis to topical brimonidine
- Is there a role for dermatologists in eating disorders?
- Medication Repurposing: New Uses for Old Drugs
- Involvement of scalp and nails in lupus erythematosus
- Interpenetrating gelatin/sodium alginate hydrogel with controlled PRP lysate delivery for accelerating diabetic wound healing with reduced scarring
- Aromatic C-nitrosation of a bioactive molecule. Nitrosation of minoxidil
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Acne in children
- Primary cicatricial alopecias
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Search Advances in Lip Skin Biology and Anti-Aging Strategies
- Identification of Familial Infections Using Multilocus Microsatellite Typing in Tinea Corporis due to <i>Microsporum canis</i>
- Disorders of the skin appendages
- Recent advances in the treatment of psoriasis
- Psychocutaneous disease
- Cutaneous manifestations of systemic lupus erythematosus
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Primary cicatricial alopecia
- Gender aspects in skin diseases
- Cutaneous Manifestations of Eating Disorders
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Thyroid hormone action on skin.
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment